Nature S Sunshine Products Inc (NATR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nature s Sunshine Products inc   (NASDAQ: NATR)


Nature S Sunshine Products Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nature S Sunshine Products Inc's ROI in the third quarter of 2026?
Nature s Sunshine Products inc achieved a return on average invested assets (ROI) of 7.94 % in its third quarter of 2026, this is above NATR's average return on investment of 7.27%.
Nature S Sunshine Products Inc invested over the 12 months ending in its third quarter of 2026 $190 million

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 107 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 447 to 743.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 2.37 % 1.79 % 1.95 % 2.15 % 2.24 %
Y / Y Net Income Change TTM -0.97 % 30.64 % 135.11 % 422.51 % 227.29 %
Investment (TTM) in Millions 195 191 190 183 187
Return On Investment (TTM) 7.94 % 9.96 % 11.1 % 11.01 % 8.21 %
NATR's Overall Ranking # 743 # 447 # 541 # 734 #
Seq. Investment Change TTM 0.98 % 0.81 % 0.31 % 0.24 % 0.42 %
Seq. Net Income Change TTM -19.49 % -9.58 % 1.14 % 34.49 % 6.21 %
Net Income (TTM) in Millions 15 19 21 20 15

NATR Company Profile >> Back to NATR Roi Comparisons >> See Annual NATR Return On Investment



Return On Investment NATR's Ranking
Within: No.
Industry # 43
Sector # 108
Overall # 743

Return On Investment Statistics
High Average Low
24.18 %
7.27 %
-11.7 %
(Sep 30 2012)   (Sep 30 2018)







Financial Statements
Nature S Sunshine Products Inc's III. Quarter Investments $ 195 Millions NATR's Balance sheet
Nature S Sunshine Products Inc's III. Quarter Income $ 2 Millions Quarterly NATR's Income Statement
NATR's Income by Division See NATR's Income by Division


NATR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 183 181 179 168 185
Y / Y Investment Growth 0.98 % 1.31 % 6.04 % -9.21 % 2.04 %
Net Income in Millions 20 8 16 1 30
Y / Y Net Income Growth 159.14 % -51.92 % 2884.73 % -98.18 % 31.58 %
Annual Return On Investment 11.2 % 4.36 % 9.2 % 0.33 % 16.29 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 11.2 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NATR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NATR's Competitors
Subscribers only: Roi for Nature S Sunshine Products Inc's Suppliers
Subscribers only: Return On Investment for NATR's Customers

Other Ratios
NATR's Roa NATR's Inventory Turnover Ratio NATR's Growth Rates NATR's Dividend Statistics
NATR's Profitability Ratios NATR's Asset Turnover Ratio NATR's Dividend Growth
NATR's Roe NATR's Valuation Ratios NATR's Financial Strength Ratios NATR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %

Date modified: 2026-11-06T12:53:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.